Drug Type Chemical drugs |
Synonyms YG 1702, YG1702 |
Target |
Action inhibitors |
Mechanism ALDH18A1 inhibitors(aldehyde dehydrogenase 18 family member A1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H30N2O7S |
InChIKeyWBMJXHUWKGEKBB-UHFFFAOYSA-N |
CAS Registry724737-08-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuroblastoma | Preclinical | China | 19 Feb 2020 | |
Neuroblastoma | Preclinical | China | 19 Feb 2020 |